Global Electromyography Devices Market Size valued at 897.75 million in 2023 and is predicted to 1444.26 million by the year 2031 at a 6.25% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The increasing incidence of neuromuscular diseases, the rising cost of healthcare worldwide, and minimally invasive procedures are expanding the market's future growth.
- The need for electromyography devices has grown in recent years due to the rising consciousness of neuromuscular diseases, and the significance of early diagnosis in achieving successful treatment is anticipated to fuel substantial industry expansion in the years ahead.
- North America dominated the market and accounted for a global revenue share in 2023.
- High costs and a need for qualified medical professionals might slow this industry's growth and raise regulatory concerns.
Skeletal muscle electrical activity is measured and recorded during a test called electromyography (EMG), also known as neuromuscular electrical signals or electromyograms. Small needle electrodes are inserted into the appropriate muscles during the procedure and connected to an amplifier afterwards. These muscular movements may be seen, heard, and heard through speakers, images projected on a screen monitor, or printed out in real-time using computer software if they can be recorded using electrodes positioned on the skin surface above them.
Electromyography (EMG) can identify electrical activity or muscle response by analyzing how the muscles react to muscle stimulation. The diagnosis process is aided by the ability of EMG to identify neuromuscular anomalies.
Recent Developments:
- In Feb 2024, RemoteX, introduced by Cometa, is compatible with every WaveX EMG IMU system. Cometa's EMG and Motion Tools software, which was delivered complimentary of charge with the acquisition of any EMG system, was completely compatible with WaveX EMG. .
Competitive Landscape:
Electromyography Devices Market Players Include:
- ADInstruments
- A-M Systems LLC.
- Ambu AS
- Biometrics Ltd.
- Cometa Srl.
- Delsys Incorporated
- Dexur
- iWorx
- Natus Medical Incorporated
- Neurosoft
Market Segmentation:
The Electromyography Devices market is segmented on the basis of product mobility, study type, product and application. Based on product mobility, the market is segmented as stationary EMG systems and portable EMG Systems. The study type segment includes nerve conduction and evoked potential. By product, the market is segmented into EMG Type (Surface EMG and Intramuscular EMG), software, electrode, and other products. On the basis of applications, segments include muscular disorders, neuro disorders, neuromuscular disorders, and other applications.
Based On Product, The Stationery EMG Segment Is Accounted As A Major Contributor In The Electromyography Devices Market
Hospitals and clinics employ stationary-type EMG devices. To ensure that the electrodes stay in touch with the skin during portable testing, stationary EMGs measure the electrical activity from a muscle or group of muscles without shifting them to a different location. This stationary-type device is appropriate for patients who do not have any movement disorders or muscular weakness because of its lightweight design, ease of mobility, and straightforward operation.
The Portable EMG Systems Segment Is Used At A Rapid Rate
When compared with stationary types, portable types are easily carried and ready for use right away. These devices are compact, making it easy for users to have them in their pockets or bags for patient convenience at any time. It assists in conducting clinical tests without the need for assistance and is simple for both patients and medical professionals to use.
In the region, the North America Electromyography Devices Market Holds A Significant Revenue Share
According to estimates, North America has the largest market share for portable electromyography equipment, and it is projected that it will resume holding this position for a few more decades due to the region's high level of electromyography awareness and increased incidence of neurological and muscular illnesses. Favourable government programmes and policies about the development of the healthcare system also assist a substantial chunk of this area. In the United States, the usage of these devices for diagnosing neuromuscular illnesses has grown due to favourable payment regulations.
Electromyography Devices Market Report Scope:
Report Attribute |
Specifications |
Growth rate CAGR |
CAGR of 6.25% from 2024 to 2031 |
Quantitative units |
Representation of revenue in US$ Billion, volume (units) and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
Segments covered |
Product Mobility, Study Type, Product And Application |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
Competitive Landscape |
ADInstruments, A-M Systems LLC, Ambu AS, Biometrics Ltd., Cometa Srl., Delsys Incorporated, Dexur, iWorx, Natus Medical Incorporated, and Neurosoft. |
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |